Schistosomiasis Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1063383
  • May 2021
  • Pharmaceuticals
  • 120 Pages
The Schistosomiasis Market research report comprises of an overall in depth-analysis such as market drivers, opportunities, restraints, latest developments and trends, segmentation of the market, competitive analysis, global as well as regional analysis by showcasing how each of these factors can improve the further growth of the market on an overall perspective. The report also showcases the overall market value which includes the historic data (2018-2019) and forecast data (2020-2028) generated through the revenue (USD Mn)
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Shin Poong Pharma.Co., Ltd., Merck & Co., Inc., Bayer AG
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Coverage
With the beginning of the COVID-19 pandemic in early 2020, all major economies around the world enforced severe lockdown restrictions to curb the spread of the virus. Apart from a few sectors such as healthcare and related essential services, most of the industries suffered tremendously due to inability to function in a normal fashion. Moreover, even some of the essential sectors suffered due to delays caused by supply chain disruptions and other travel complexities. However, with massive vaccination drives in most of the developed economies, some of the economies across the world experienced economic recovery from 2021. The Schistosomiasis market is expected to gain momentum in such economies and probably recover some of the losses inflicted in the year 2020. With continued efforts towards curbing the virus in the developing economies, the Schistosomiasis market is expected to attain Pre COVID-19 levels by mid-2022.

Schistosomiasis Report’s Assessment
The research report is formulated such that it offers a deep understating on the market drivers that are assimilating the growth of the market, the market opportunities that are going to provide future growth factors for the market and the market restraints which showcase the reasons as to why the market can get hampered and dissimilated. All these factors are considered keeping in view the historic and forecast analysis which can enlighten the above mentioned factors.

Thereby at a glance a reader can understand all the factors and prospects of the Schistosomiasis market and how it can assimilate and dissimilate based on each of the factors and figures mentioned in the report

Schistosomiasis Market Competitive and Premeditated Analysis
In the Schistosomiasis report major factors such latest tactical developments, competitors, research and development, participation of each region in the market and the competition among them, the latest news regarding company acquisitions and product launch, revenue of the competitors as well as the key offerings they provide all these factors are mentioned in the report with reasons to justify and understand them in depth.

The readers and purchaser of the Schistosomiasis research report can gain a comprehensive understanding of the market competition, the revenue of each major players and their contribution towards the market, attractive proposition analysis is provided in the report which sub divides the segments with respect to the largest segment that has contributed to the market growth and the fastest growing segment based on the size of the market as well as its overall appeal.
 
Major Key Players for Global Schistosomiasis Market:
The Schistosomiasis market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Shin Poong Pharma.Co., Ltd., Merck & Co., Inc., Bayer AG

The Schistosomiasis market report showcases vast potentials of growth and assimilation which is going to provide the industry numerous opportunities to grow and generate revenue by understanding the segments and which segment is a potential part to increase the disposable income in the present and upcoming years.

Schistosomiasis Market Segmentation Analysis:
Each of the segment is explained in brief along with the revenue it generates for the market based on the historic and forecast data by highlighting the largest segment and the fastest growing segment with reasons to justify it.

The Global segmentation of the Schistosomiasis market:
By Site
Intestinal
Urogenital
Drug Type
Praziquantel
Metrifonate
Oxamniquine

Regional Analysis of the Schistosomiasis market:
The Schistosomiasis market is dived based on different regions such as North America, Europe, Asia Pacific, Latin America and the Middle East and Africa. And the analysis of each region is provided by highlighting the largest contribution region, the fastest growing region and the factors that is keeping the market active in the other regions is also mentioned in depth. Each regional segment also comprises of the revenue each segment holds in a specific region with reasons to justify the values.

By Regions:
  • North America (U.S and Canada)
  • Europe (U.K., Germany and France)
  • Asia Pacific (China, India and Japan)
  • Latin America (Mexico and Brazil)
  • Middle East and Africa (GCC Countries and South Africa)
 


Major Factors Included and highlighted in the Schistosomiasis report are as follows:
  • The overall market value along with historic and future data analysis.
  • The Growth drivers, opportunities and restraints are mention in detail.
  • The size of the entire Schistosomiasis market on a global perspective.
  • The CAGR value of the overall market from 2020 to 2028.
  • COVID-19 impact on the Schistosomiasis market and how it is coping up with the situation.
  • Major competitors and their contribution towards the market.
  • The segmentation analysis is included which provides a clear picture of the market bifurcation.
  • Tables and graphs that can easily been understood at a glance
  • Latest trends and news related to the Schistosomiasis market is included in the report.
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Schistosomiasis market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Schistosomiasis market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Schistosomiasis market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Schistosomiasis market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Schistosomiasis market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Schistosomiasis Market Snapshot
          2.1.1. Global Schistosomiasis Market By Site,2019
               2.1.1.1.Intestinal
               2.1.1.2.Urogenital
          2.1.2. Global Schistosomiasis Market By Drug Type,2019
               2.1.2.1.Praziquantel
               2.1.2.2.Metrifonate
               2.1.2.3.Oxamniquine
          2.1.3. Global Schistosomiasis Market By End-use,2019
          2.1.4. Global Schistosomiasis Market By Geography,2019

3. Global Schistosomiasis Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Schistosomiasis Market Size (US$), By Site, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Site, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Site, 2020
     4.2. Global Schistosomiasis Market Size (US$), By Site, 2018 – 2028

5. Global Schistosomiasis Market Size (US$), By Drug Type, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Drug Type, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Drug Type, 2020
     5.2. Global Schistosomiasis Market Size (US$), By Drug Type, 2018 – 2028

6. Global Schistosomiasis Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Schistosomiasis Market Size (US$), By End-use, 2018 – 2028

7. Global Schistosomiasis Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Schistosomiasis Market Analysis, 2018 – 2028 
          7.2.1. North America Schistosomiasis Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Schistosomiasis Market Size (US$), By Site, 2018 – 2028
          7.2.3. North America Schistosomiasis Market Size (US$), By Drug Type, 2018 – 2028
          7.2.4. North America Schistosomiasis Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Schistosomiasis Market Analysis, 2018 – 2028 
          7.3.1.  Europe Schistosomiasis Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Schistosomiasis Market Size (US$), By Site, 2018 – 2028
          7.3.3. Europe Schistosomiasis Market Size (US$), By Drug Type, 2018 – 2028
          7.3.4. Europe Schistosomiasis Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Schistosomiasis Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Schistosomiasis Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Schistosomiasis Market Size (US$), By Site, 2018 – 2028
          7.4.3. Asia Pacific Schistosomiasis Market Size (US$), By Drug Type, 2018 – 2028
          7.4.4. Asia Pacific Schistosomiasis Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Schistosomiasis Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Schistosomiasis Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Schistosomiasis Market Size (US$), By Site, 2018 – 2028
          7.5.3. Latin America Schistosomiasis Market Size (US$), By Drug Type, 2018 – 2028
          7.5.4. Latin America Schistosomiasis Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Schistosomiasis Market Analysis, 2018 – 2028 
          7.6.1.  MEA Schistosomiasis Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Schistosomiasis Market Size (US$), By Site, 2018 – 2028
          7.6.3. MEA Schistosomiasis Market Size (US$), By Drug Type, 2018 – 2028
          7.6.4. MEA Schistosomiasis Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Schistosomiasis Providers
        8.4.1 Shin Poong Pharma.Co., Ltd.
                8.4.1.1 Business Description
                8.4.1.2 Shin Poong Pharma.Co., Ltd. Geographic Operations
                8.4.1.3 Shin Poong Pharma.Co., Ltd. Financial Information
                8.4.1.4 Shin Poong Pharma.Co., Ltd. Product Positions/Portfolio
                8.4.1.5 Shin Poong Pharma.Co., Ltd. Key Developments
        8.4.2 Merck & Co., Inc.
                8.4.2.1 Business Description
                8.4.2.2 Merck & Co., Inc. Geographic Operations
                8.4.2.3 Merck & Co., Inc. Financial Information
                8.4.2.4 Merck & Co., Inc. Product Positions/Portfolio
                8.4.2.5 Merck & Co., Inc. Key Developments
        8.4.3 Bayer AG
                8.4.3.1 Business Description
                8.4.3.2 Bayer AG Geographic Operations
                8.4.3.3 Bayer AG Financial Information
                8.4.3.4 Bayer AG Product Positions/Portfolio
                8.4.3.5 Bayer AG Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Schistosomiasis Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Schistosomiasis Market Revenue, By Site, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Schistosomiasis Market Revenue, By Drug Type, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Schistosomiasis Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Schistosomiasis Market Revenue, By Site, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Schistosomiasis Market Revenue, By Drug Type, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Schistosomiasis Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Schistosomiasis Market Revenue, By Site, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Schistosomiasis Market Revenue, By Drug Type, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Schistosomiasis Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Schistosomiasis Market Revenue, By Site, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Schistosomiasis Market Revenue, By Drug Type, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Schistosomiasis Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Schistosomiasis Market Revenue, By Site, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Schistosomiasis Market Revenue, By Drug Type, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Schistosomiasis Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Schistosomiasis: Market Segmentation 
FIG. 2 Global Schistosomiasis Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Schistosomiasis Market, By Site, 2019 (US$ Mn) 
FIG. 5 Global Schistosomiasis Market, By Drug Type, 2019 (US$ Mn) 
FIG. 6 Global Schistosomiasis Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Schistosomiasis Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Schistosomiasis Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Schistosomiasis Providers, 2019
FIG. 11 Global Schistosomiasis Market Revenue Contribution, By Site, 2019 & 2028 (Value %) 
FIG. 12 Global Schistosomiasis Market Revenue Contribution, By Drug Type, 2019 & 2028 (Value %) 
FIG. 13 Global Schistosomiasis Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Schistosomiasis Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Schistosomiasis Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Schistosomiasis Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Schistosomiasis Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Schistosomiasis Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Schistosomiasis market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Schistosomiasis Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Schistosomiasis Market Value, By Segment1, 2018 – 2028
TABLE  North America Schistosomiasis Market Value, By Segment2, 2018 – 2028
TABLE  North America Schistosomiasis Market Value, By Country, 2018 – 2028
TABLE  Europe Schistosomiasis Market Value, By Segment1, 2018 – 2028
TABLE  Europe Schistosomiasis Market Value, By Segment2, 2018 – 2028
TABLE  Europe Schistosomiasis Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Schistosomiasis Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Schistosomiasis Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Schistosomiasis Market Value, By Country, 2018 – 2028
TABLE  Latin America Schistosomiasis Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Schistosomiasis Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Schistosomiasis Market Value, By Country, 2018 – 2028
TABLE  MEA Schistosomiasis Market Value, By Segment1, 2018 – 2028
TABLE  MEA Schistosomiasis Market Value, By Segment2, 2018 – 2028
TABLE  MEA Schistosomiasis Market Value, By Country, 2018 – 2028
TABLE  Shin Poong Pharma.Co., Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Merck & Co., Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Bayer AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Schistosomiasis Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Schistosomiasis Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Schistosomiasis Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Schistosomiasis Market, By Geography, 2019 (US$ Mn)
FIG.  Global Schistosomiasis Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Schistosomiasis Providers, 2016
FIG.  Global Schistosomiasis Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Urogenital Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Schistosomiasis Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Metrifonate Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Oxamniquine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Schistosomiasis Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Schistosomiasis Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Schistosomiasis Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Schistosomiasis Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Schistosomiasis Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Schistosomiasis Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Schistosomiasis Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Schistosomiasis Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Schistosomiasis Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Schistosomiasis Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Schistosomiasis Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Schistosomiasis Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Schistosomiasis Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Schistosomiasis Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Schistosomiasis Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Schistosomiasis Market Value, 2018 – 2028, (US$ Mn)